Innoviva (INVA) Convertible Debt (2010 - 2017)
Innoviva (INVA) posted Convertible Debt of $237.9 million for Q2 2017, little changed on a QoQ basis from $237.7 million in Q1 2017, and down 1.47% year-over-year from $241.4 million in Q2 2016.
Innoviva (INVA) Convertible Debt (2010 - 2017) Analysis & Trends
Innoviva's Convertible Debt history runs 8 years deep, the most recent figure standing at $237.9 million for Q2 2017.
- Quarterly Convertible Debt fell 1.47% year-over-year to $237.9 million in Q2 2017, while the trailing twelve-month figure through Jun 2017 was $237.9 million (down 1.47% YoY) and the FY2016 annual result came in at $237.6 million, down 5.34% from the prior year.
- Convertible Debt was $237.9 million for Q2 2017 at Innoviva, roughly flat from $237.7 million in the prior quarter.
- Across five years, Convertible Debt topped out at $460.0 million in Q1 2013 and bottomed at $237.6 million in Q4 2016.
- A 5-year average of $280.2 million and a median of $255.1 million in 2014 frame the typical range for Convertible Debt.
- Annual changes were most pronounced in 2013 — Convertible Debt surged 166.67% — and 2014, when it slumped 37.5%.
- Innoviva's Convertible Debt stood at $287.5 million in 2013, then dropped by 11.27% to $255.1 million in 2014, then retreated by 1.61% to $251.0 million in 2015, then slipped by 5.34% to $237.6 million in 2016, then advanced by 0.11% to $237.9 million in 2017.
- Business Quant data shows INVA's Convertible Debt at $237.9 million in Q2 2017, $237.7 million in Q1 2017, and $237.6 million in Q4 2016.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | 237.86 Mn |
| Mar 31, 2017 | 237.72 Mn |
| Dec 31, 2016 | 237.60 Mn |
| Sep 30, 2016 | 241.54 Mn |
| Jun 30, 2016 | 241.41 Mn |
| Mar 31, 2016 | 251.12 Mn |
| Dec 31, 2015 | 250.99 Mn |
| Sep 30, 2015 | 255.11 Mn |
| Jun 30, 2015 | 255.11 Mn |
| Mar 31, 2015 | 255.11 Mn |
| Dec 31, 2014 | 255.11 Mn |
| Sep 30, 2014 | 255.11 Mn |
| Jun 30, 2014 | 287.50 Mn |
| Mar 31, 2014 | 287.50 Mn |
| Dec 31, 2013 | 287.50 Mn |
| Sep 30, 2013 | 287.50 Mn |
| Jun 30, 2013 | 459.96 Mn |
| Mar 31, 2013 | 460.00 Mn |
| Dec 31, 2012 | 172.50 Mn |
| Sep 30, 2012 | 172.50 Mn |